| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
| filingDate |
1992-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab01356ebd98c75d7a8c985e957c81a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcdfc623fbcc5a3d8adcbcb1040e704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a13d9a74d2dc9f0f18b204bbcd2ac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382d3dd61253f891f3e85e461e5e741a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f329005ddf6fd0aabb9a1d6ad8f36d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf5a7dbacfa37fef1338eed6d6b338f6 |
| publicationDate |
1994-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H06211841-A |
| titleOfInvention |
β-carboline-derived compounds, benzodiazepine receptor ligands having inverse agonistic and antagonistic effects, and drugs containing the same |
| abstract |
(57) [Summary] [Objective] To obtain a novel β-carboline-derived compound which is a benzodiazepine receptor ligand having an inverse agonistic and antagonistic action on benzodiazepine. [Structure] A corresponding tetrahydro derivative of β-carboline represented by the following formula 1 and a pharmaceutically acceptable quaternary ammonium salt or derivative compound thereof. [Chemical 1] |
| priorityDate |
1991-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |